Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection

NCT02250807 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C
Genotype 4 Chronic Hepatitis C

Interventions

DRUG: Simeprevir
DRUG: Sofosbuvir

Sponsor

Janssen R&D Ireland